Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
-
AstraZeneca makes regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer in Japan
-
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
-
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib
-
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
-
Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma
-
Year-To-Date and Q3 2017 Results
-
AstraZeneca shares scientific updates from its extensive cardiovascular, renal and metabolic diseases (CVMD) portfolio at AHA 2017
-
AstraZeneca provides update on tralokinumab Phase III programme in severe, uncontrolled asthma
-
US FDA approves AstraZeneca’s Calquence (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
